The EMA's Product Management Services will serve as a comprehensive database for consistent identification of medicines internationally. One deadline is quickly approaching on May 31. Are you ready?
- What's The Risk Of Letting Researchers Use LLMs?
- Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action
- Celebrating Clinical Trials Day, Part 1: Putting The Patient First
- Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources
- Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One
- How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two
- Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake
GUEST COLUMNISTS
-
Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards.
-
Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake
How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.
-
5 Ways AI Is Changing Clinical Research — And How To Embrace It
Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.
-
Going With The Group: Improve Recruitment With Social Psychology And Behavioral Science, Part 2
In part two of this series, Tatty Scott explores what social psychology tells us about the magnetic pull of groups on individuals’ behavior and how outreach group engagement activities can maximize behavior change to improve recruitment.
-
Improve Patient Recruitment Using Behavioral Science? It's A No-Brainer, Part One
In part one of this series, recruitment expert Tatty Scott explores the ways behavioral science — such as nudging the brain’s autopilot — can help change patient behavior and sentiment toward trial participation.
-
AI In Medical Devices: Meeting The Regulatory Challenge Around The World, Part 2
This article focuses on the common regulatory threads that connect different regions and the global standards and principles being developed to bring consistency, safety, and trust to AI innovation in medical devices.
-
3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization
CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.
-
How Recursion Is Industrializing Clinical Trials With AI
Recursion SVP of Clinical Development and Data Science Sid Jain discusses the company's three-point "ClinTech" strategy, focusing on AI-assisted trial design, trial execution, and evidence generation.
CLINICAL TRIAL WHITE PAPERS
-
Diffuse Large B-Cell Lymphoma- Global Clinical Trial Landscape
Explore the latest advancements in diffuse large B-cell lymphoma research, innovative therapies, and personalized care strategies shaping the future of treatment.
-
Achieving Statistical Significance With Limited Patient Populations3/15/2024
Explore highlights from a timely panel debate on emerging approaches to clinical research and data collection for advanced, novel and personalized therapies, especially linked to rare diseases.
-
Ensuring A Diverse Patient Population In Clinical Trials12/13/2024
In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.
-
A Guide To Digital Endpoints In Major Depressive Disorder3/7/2025
The integration of digital health technologies (DHTs) in clinical trials for Major Depressive Disorder (MDD) is transforming how symptom severity and treatment efficacy are measured.
-
The Rescue Option: Course Correcting Struggling Clinical Trials4/14/2025
The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.
-
Cervical Cancer - Global Clinical Trial Landscape (2024)10/15/2024
Expand your understanding of the cervical cancer (CC) clinical trial landscape, including current drug development funding, and the effect of this disease on the world.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Pioneering The End-To-End Decentralized Trial Experience4/16/2025
Explore a collaboration between a top 20 pharmaceutical company and Medidata that highlights the potential of DCTs to transform trial execution, offering a replicable model for future research.
-
Data Management Solution For A Clinical-Stage Cancer Immunotherapy Study7/23/2024
Check out the results from a clinical first-in-human study evaluating the safety and tolerability of an investigational cancer immunotherapy in patients with advanced melanoma.
-
Integrated Strategies for Achieving Regulatory Milestones Faster10/12/2023
Learn how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.
-
RTSM And Clinical Drug Dispensation7/16/2024
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Rating Services Improve Signal Detection In Depressive Disorder Trials8/29/2023
Delve into a comprehensive understanding of several impactful contributions made during five MDD clinical trials and their outcomes.
-
RWD For Early Clinical Development Planning And Strategy9/19/2023
Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.
NEWSLETTER ARCHIVE
- 05.22.25 -- How To Pick The Perfect Clinical Trial Partners
- 05.22.25 -- What's New In Early-Phase Clinical Research?
- 05.21.25 -- Track Your Trial's Carbon Footprint With This Sustainability Calculator
- 05.21.25 -- STREAM Edition: Tailored Sponsor Engagement Key To Unlocking Site Network Efficiency
- 05.20.25 -- How Recursion Is Industrializing Clinical Trials With AI

RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
Servier Pharmaceuticals' Susan Pandya discusses how sponsors can translate a belief in patient centricity into action by creating more accessible, inclusive, and patient-friendly pathways to participation.
-
Celebrate Clinical Trials Day 2025 with these industry experts sharing their experiences and advice for putting the patient first.
-
Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.
FOCUS ON PATIENTS
-
Servier Pharmaceuticals' Susan Pandya discusses how sponsors can translate a belief in patient centricity into action by creating more accessible, inclusive, and patient-friendly pathways to participation.
-
Celebrate Clinical Trials Day 2025 with these industry experts sharing their experiences and advice for putting the patient first.
-
The Peggy Lillis Foundation CEO Christian John Lillis discusses his experience advocating for C. diff therapies, highlighting some successes as well as shortcomings in feeling heard.